I. J. Amanna, N. E. Carlson, and M. K. Slifka, Duration of humoral immunity to common viral and vaccine antigens, N Engl J Med, vol.357, pp.1903-1915, 2007.

R. A. Manz, A. Thiel, and A. Radbruch, Lifetime of plasma cells in the bone marrow, Nature, vol.388, issue.6638, pp.133-134, 1997.

M. K. Slifka, R. Antia, J. K. Whitmire, and R. Ahmed, Humoral immunity due to long-lived plasma cells, Immunity, vol.8, issue.3, pp.363-372, 1998.

A. Ahuja, S. M. Anderson, A. Khalil, and M. J. Shlomchik, Maintenance of the plasma cell pool is independent of memory B cells, ProcNatlAcadSci U S A, vol.105, issue.12, pp.4802-4807, 2008.

D. J. Dilillo, Maintenance of long-lived plasma cells and serological memory despite mature andmemory B cell depletion during CD20 immunotherapy in mice, J Immunol, vol.180, issue.1, pp.361-371, 2008.

S. G. Tangye, Staying alive: regulation of plasma cell survival, TrendsImmunol, vol.32, issue.12, pp.595-602, 2011.

H. A. Minges-wols, G. H. Underhill, G. S. Kansas, and P. L. Witte, The role of bone marrow-derived stromal cells in the maintenance of plasma cell longevity, J Immunol, vol.169, issue.8, pp.4213-4221, 2002.

V. T. Chu, Eosinophils are required for the maintenance of plasma cells in the bone marrow, Nat Immunol, vol.12, issue.2, pp.151-159, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00613147

G. Cassese, Plasma cell survival is mediated by synergistic effects of cytokines and adhesiondependent signals, J Immunol, vol.171, issue.4, pp.1684-1690, 2003.

B. F. Hoyer, Short-lived plasmablasts and long-lived plasma cells contribute to chronic humoral autoimmunity in NZB/W mice, J Exp Med, vol.199, issue.11, pp.1577-1584, 2004.

J. C. Edwards, Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis, N Engl J Med, vol.350, issue.25, pp.2572-2581, 2004.

J. H. Stone, Rituximab versus cyclophosphamide for ANCA-associated vasculitis, N Engl J Med, vol.363, issue.3, pp.221-232, 2010.

V. Devauchelle-pensec, Treatment of primary Sjögren syndrome with rituximab: a randomized trial, Ann Intern Med, vol.160, issue.4, pp.233-242, 2014.

J. T. Merrill, Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial, Arthritis Rheum, vol.62, issue.1, pp.222-233, 2010.

B. H. Rovin, Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the Lupus Nephritis Assessment with Rituximab study, Arthritis Rheum, vol.64, issue.4, pp.1215-1226, 2012.

R. Stasi, A. Pagano, E. Stipa, and S. Amadori, Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura, Blood, vol.98, issue.4, pp.952-957, 2001.

M. Mahévas, B cell depletion in immune thrombocytopenia reveals splenic long-lived plasma cells, J Clin Invest, vol.123, issue.1, pp.432-442, 2013.

M. Mahévas, Emergence of long-lived autoreactive plasma cells in the spleen of primary warm auto-immune hemolytic anemia patients treated with rituximab, J Autoimmun, vol.62, pp.22-30, 2015.

I. Dogan, Multiple layers of B cell memory with different effector functions, Nat Immunol, vol.10, issue.12, pp.1292-1299, 2009.

W. Shi, Transcriptional profiling of mouse B cell terminal differentiation defines a signature for antibody-secreting plasma cells, Nat Immunol, vol.16, issue.6, pp.663-73, 2015.

S. Gardam and R. Brink, Non-Canonical NF-?B Signaling Initiated by BAFF Influences B Cell Biology at Multiple Junctures. Front Immunol, vol.6, p.509, 2014.

F. B. Vincent, D. Saulep-easton, W. A. Figgett, K. A. Fairfax, and F. Mackay, The BAFF/APRIL system: emerging functions beyond B cell biology and autoimmunity, Cytokine Growth Factor Rev, vol.24, issue.3, pp.203-215, 2013.

M. J. Benson, Cutting edge: the dependence of plasma cells and independence of memory B cells on BAFF and APRIL, J Immunol, vol.180, issue.6, pp.3655-3659, 2008.

K. W. Bekar, Prolonged effects of short-term anti-CD20 B cell depletion therapy in murine systemic lupus erythematosus, Arthritis Rheum, vol.62, issue.8, pp.2443-2457, 2010.

W. Lin, Dual B cell immunotherapy is superior to individual anti-CD20 depletion or BAFF blockade in murine models of spontaneous or accelerated lupus, Arthritis Rheumatol, vol.67, issue.1, pp.215-224, 2015.

I. Puga, B cell-helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen, Nat Immunol, vol.13, issue.2, pp.170-180, 2011.

D. R. Withers, C. Fiorini, R. T. Fischer, R. Ettinger, P. E. Lipsky et al., T cell-dependent survival of CD20+ and CD20-plasma cells in human secondary lymphoid tissue, Blood, vol.109, issue.11, pp.4856-4864, 2007.

M. Mahévas, M. Michel, J. C. Weill, and C. A. Reynaud, Long-lived plasma cells in autoimmunity: lessons from B-cell depleting therapy, Front Immunol, vol.4, p.494, 2013.

D. Bagnara, M. Squillario, D. Kipling, T. Mora, A. M. Walczak et al., A Reassessment of IgM Memory Subsets in Humans, J Immunol, vol.195, pp.3716-3724, 2015.

D. Baumjohann, S. Preite, A. Reboldi, F. Ronchi, K. M. Ansel et al., Persistent antigen and germinal center B cells sustain T follicular helper cell responses and phenotype, Immunity, vol.38, pp.596-605, 2013.

Y. Belkaid, N. Bouladoux, and T. W. Hand, Effector and memory T cell responses to commensal bacteria, Trends Immunol, vol.34, pp.299-306, 2013.

M. A. Berkowska, G. J. Driessen, V. Bikos, C. Grosserichter-wagener, K. Stamatopoulos et al., Human memory B cells originate from three distinct germinal center-dependent and -independent maturation pathways, Blood, vol.118, pp.2150-2158, 2011.

M. A. Berkowska, J. N. Schickel, C. Grosserichter-wagener, D. De-ridder, Y. S. Ng et al., Circulating Human CD27-IgA+ Memory B Cells Recognize Bacteria with Polyreactive Igs, J Immunol, vol.195, pp.1417-1426, 2015.

B. Budeus, S. Schweigle-de-reynoso, M. Przekopowitz, D. Hoffmann, M. Seifert et al., Complexity of the human memory B-cell compartment is determined by the versatility of clonal diversification in germinal centers, Proc Natl Acad Sci U S A, vol.112, pp.5281-5289, 2015.

I. Dogan, B. Bertocci, V. Vilmont, F. Delbos, J. Megret et al., Multiple layers of B cell memory with different effector functions, Nat Immunol, vol.10, pp.1292-1299, 2009.

P. P. Domeier, S. B. Chodisetti, C. Soni, S. L. Schell, M. J. Elias et al., IFN-gamma receptor and STAT1 signaling in B cells are central to spontaneous germinal center formation and autoimmunity, J Exp Med, vol.213, pp.715-732, 2016.

M. R. Ehrenstein and C. A. Notley, The importance of natural IgM: scavenger, protector and regulator, Nat Rev Immunol, vol.10, pp.778-786, 2010.

M. Gomez-de-aguero, S. C. Ganal-vonarburg, T. Fuhrer, S. Rupp, Y. Uchimura et al., The maternal microbiota drives early postnatal innate immune development, Science, vol.351, pp.1296-1302, 2016.

M. Jarjour, A. Jorquera, I. Mondor, S. Wienert, P. Narang et al., Fate mapping reveals origin and dynamics of lymph node follicular dendritic cells, J Exp Med, vol.211, pp.1109-1122, 2014.

T. Kaji, A. Ishige, M. Hikida, J. Taka, A. Hijikata et al., Distinct cellular pathways select germline-encoded and somatically mutated antibodies into immunological memory, J Exp Med, vol.209, pp.2079-2097, 2012.

M. Kuraoka, T. M. Holl, D. Liao, M. Womble, D. W. Cain et al., , 2011.

, Activation-induced cytidine deaminase mediates central tolerance in B cells, Proc Natl Acad Sci U S A, vol.108, pp.11560-11565

B. Laffleur, S. Duchez, K. Tarte, N. Denis-lagache, S. Peron et al., Self-Restrained B Cells Arise following Membrane IgE Expression, Cell Rep, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01116949

C. Lindner, I. Thomsen, B. Wahl, M. Ugur, M. K. Sethi et al., Diversification of memory B cells drives the continuous adaptation of secretory antibodies to gut microbiota, Nat Immunol, vol.16, pp.880-888, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01604354

C. Lindner, B. Wahl, L. Fohse, S. Suerbaum, A. J. Macpherson et al., Age, microbiota, and T cells shape diverse individual IgA repertoires in the intestine, J Exp Med, vol.209, pp.365-377, 2012.

A. J. Macpherson, M. B. Geuking, E. Slack, S. Hapfelmeier, and K. D. Mccoy, The habitat, double life, citizenship, and forgetfulness of IgA, Immunol Rev, vol.245, pp.132-146, 2012.

M. Mahevas, P. Patin, F. Huetz, M. Descatoire, N. Cagnard et al., B cell depletion in immune thrombocytopenia reveals splenic long-lived plasma cells, J Clin Invest, vol.123, pp.432-442, 2013.
URL : https://hal.archives-ouvertes.fr/pasteur-00778075

F. Martin and J. F. Kearney, Marginal-zone B cells, Nat Rev Immunol, vol.2, pp.323-335, 2002.

T. Nojima, K. Haniuda, T. Moutai, M. Matsudaira, S. Mizokawa et al., In-vitro derived germinal centre B cells differentially generate memory B or plasma cells in vivo, Nat Commun, vol.2, p.465, 2011.

A. F. Ochsenbein, T. Fehr, C. Lutz, M. Suter, F. Brombacher et al., Control of early viral and bacterial distribution and disease by natural antibodies, Science, vol.286, pp.2156-2159, 1999.

M. Proietti, V. Cornacchione, T. Rezzonico-jost, A. Romagnani, C. E. Faliti et al., ATP-gated ionotropic P2X7 receptor controls follicular T helper cell numbers in Peyer's patches to promote host-microbiota mutualism, Immunity, vol.41, pp.789-801, 2014.

I. Puga, M. Cols, C. M. Barra, B. He, L. Cassis et al., B cell-helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen, Nat Immunol, vol.13, pp.170-180, 2012.

A. E. Reynolds, M. Kuraoka, and G. Kelsoe, Natural IgM is produced by CD5-plasma cells that occupy a distinct survival niche in bone marrow, J Immunol, vol.194, pp.231-242, 2015.

M. Seifert, M. Przekopowitz, S. Taudien, A. Lollies, V. Ronge et al., Functional capacities of human IgM memory B cells in early inflammatory responses and secondary germinal center reactions, Proc Natl Acad Sci U S A, vol.112, pp.546-555, 2015.

C. Soni, E. B. Wong, P. P. Domeier, T. N. Khan, T. Satoh et al., B cell-intrinsic TLR7 signaling is essential for the development of spontaneous germinal centers, J Immunol, vol.193, pp.4400-4414, 2014.

J. M. Tas, L. Mesin, G. Pasqual, S. Targ, J. T. Jacobsen et al., Visualizing antibody affinity maturation in germinal centers, Science, vol.351, pp.1048-1054, 2016.

J. J. Taylor, K. A. Pape, and M. K. Jenkins, A germinal center-independent pathway generates unswitched memory B cells early in the primary response, J Exp Med, vol.209, pp.597-606, 2012.

M. C. Thurnheer, A. W. Zuercher, J. J. Cebra, and N. A. Bos, B1 cells contribute to serum IgM, but not to intestinal IgA, production in gnotobiotic Ig allotype chimeric mice, J Immunol, vol.170, pp.4564-4571, 2003.

A. M. Trama, M. A. Moody, S. M. Alam, F. H. Jaeger, B. Lockwood et al., HIV-1 envelope gp41 antibodies can originate from terminal ileum B cells that share cross-reactivity with commensal bacteria, Cell Host Microbe, vol.16, pp.215-226, 2014.

G. T. Williams, C. J. Jolly, J. Kohler, and M. S. Neuberger, The contribution of somatic hypermutation to the diversity of serum immunoglobulin: dramatic increase with age, Immunity, vol.13, pp.409-417, 2000.

W. B. Williams, H. X. Liao, M. A. Moody, T. B. Kepler, S. M. Alam et al., HIV-1 VACCINES. Diversion of HIV-1 vaccine-induced immunity by gp41-microbiota cross-reactive antibodies, Retrovirology, vol.349, p.59, 1253.

P. Yu, W. Lubben, H. Slomka, J. Gebler, M. Konert et al., Nucleic acid-sensing Toll-like receptors are essential for the control of endogenous retrovirus viremia and ERV-induced tumors, Immunity, vol.37, pp.867-879, 2012.

M. Y. Zeng, D. Cisalpino, S. Varadarajan, J. Hellman, H. S. Warren et al., Gut Microbiota-Induced Immunoglobulin G Controls Systemic Infection by Symbiotic Bacteria and Pathogens, Immunity, vol.44, pp.647-658, 2016.

G. V. Zuccarino-catania, S. Sadanand, F. J. Weisel, M. M. Tomayko, H. Meng et al., CD80 and PD-L2 define functionally distinct memory B cell subsets that are independent of antibody isotype, Nat Immunol, vol.15, pp.631-637, 2014.

. V-bibliographie,

A. Ahuja, S. M. Anderson, A. Khalil, and M. J. Shlomchik, Maintenance of the plasma cell pool is independent of memory B cells, Proc Natl Acad Sci, vol.105, issue.12, pp.4802-4809, 2008.

A. Ahuja, J. Shupe, R. Dunn, M. Kashgarian, M. R. Kehry et al., Depletion of B cells in murine lupus: efficacy and resistance, J Immunol, vol.179, issue.5, pp.3351-61, 2007.

T. Alexander, R. Sarfert, J. Klotsche, A. A. Kühl, A. Rubbert-roth et al., The proteasome inhibitior bortezomib depletes plasma cells and ameliorates clinical manifestations of refractory systemic lupus erythematosus, Ann Rheum Dis, vol.74, issue.7, pp.1474-1482, 2015.

T. Alexander, A. Thiel, O. Rosen, G. Massenkeil, A. Sattler et al., Depletion of autoreactive immunologic memory followed by autologous hematopoietic stem cell transplantation in patients with refractory SLE induces long-term remission through de novo generation of a juvenile and tolerant immune system, Blood, vol.113, issue.1, pp.214-237, 2009.

C. D. Allen, T. Okada, H. L. Tang, and J. G. Cyster, Imaging of germinal center selection events during affinity maturation, Science, vol.315, issue.5811, pp.528-559, 2007.

C. D. Allen, T. Okada, and J. G. Cyster, Germinal-center organization and cellulardynamics. Immunity.2007 b, vol.27, pp.190-202

D. Allman, R. C. Lindsley, W. Demuth, K. Rudd, S. A. Shinton et al., Resolution of three nonproliferative immature splenic B cell subsets reveals multiple selection points during peripheral B cell maturation, J Immunol, vol.167, issue.12, pp.6834-6874, 2001.

K. R. Alugupalli, J. M. Leong, R. T. Woodland, M. Muramatsu, T. Honjo et al., B1b lymphocytes confer T cell-independent long-lasting immunity, Immunity, vol.21, issue.3, pp.379-90, 2004.

I. J. Amanna, N. E. Carlson, and M. K. Slifka, Duration of humoral immunity to common viral and vaccine antigens, N Engl J Med, vol.357, pp.1903-1918, 2007.

J. H. Anolik, J. Barnard, T. Owen, B. Zheng, S. Kemshetti et al., Delayed memory B cell recovery in peripheral blood and lymphoid tissue in systemic lupus erythematosus after B cell depletion therapy, Arthritis Rheum, vol.56, issue.9, pp.3044-56, 2007.

J. H. Anolik, J. Barnard, A. Cappione, A. E. Pugh-bernard, R. E. Felgar et al., Rituximab improves peripheral B cell abnormalities in human systemic lupus erythematosus, Arthritis Rheum, vol.50, issue.11, pp.3580-90, 2004.

J. H. Anolik, D. Campbell, R. E. Felgar, F. Young, I. Sanz et al., The relationship of FcgammaRIIIa genotype to degree of B cell depletion by rituximab in the treatment of systemic lupus erythematosus, Arthritis Rheum, vol.48, issue.2, pp.455-464, 2003.

D. T. Avery, J. I. Ellyard, F. Mackay, L. M. Corcoran, P. D. Hodgkin et al., Increased expression of CD27 on activated human memory B cells correlates with their commitment to the plasma cell lineage, J Immunol, vol.174, issue.7, pp.4034-4076, 2005.

D. T. Avery, S. L. Kalled, J. I. Ellyard, C. Ambrose, S. A. Bixler et al., BAFF selectively enhances the survival of plasmablasts generated from human memory B cells, J Clin Invest, vol.112, issue.2, pp.286-97, 2003.

K. Balabanian, J. Couderc, L. Bouchet-delbos, A. A. Berrebi, D. Foussat et al., Role of the chemokine stromal cellderived factor 1 in autoantibody production and nephritis in murine lupus, J Immunol, vol.170, issue.6, pp.3392-400, 2003.
URL : https://hal.archives-ouvertes.fr/pasteur-00166866

M. Balázs, F. Martin, T. Zhou, and J. Kearney, Blood dendritic cells interact with splenic marginal zone B cells to initiate T-independent immune responses, Immunity, vol.17, issue.3, pp.341-52, 2002.

F. D. Batista and N. E. Harwood, The who, how and where of antigen presentation to B cells, Nat Rev Immunol, vol.9, issue.1, pp.15-27, 2009.

N. Baumgarth, O. C. Herman, G. C. Jager, L. E. Brown, L. A. Herzenberg et al., B-1 and B-2 cell-derived immunoglobulin M antibodies are nonredundant components of the protective response to influenza virus infection, J Exp Med, vol.192, issue.2, pp.271-80, 2000.

N. Baumgarth, O. C. Herman, G. C. Jager, L. Brown, L. A. Herzenberg et al., Innate and acquired humoral immunities to influenza virus are mediated by distinct arms of the immune system, Proc Natl Acad Sci, vol.96, issue.5, pp.2250-2255, 1999.

K. W. Bekar, T. Owen, R. Dunn, T. Ichikawa, W. Wang et al., Prolonged effects of short-term anti-CD20 B cell depletion therapy in murine systemic lupus erythematosus, Arthritis Rheum, vol.62, issue.8, pp.2443-57, 2010.

E. Belnoue, C. Tougne, A. F. Rochat, P. H. Lambert, D. D. Pinschewer et al., Homing and adhesion patterns determine the cellular composition of the bone marrow plasma cell niche, J Immunol, vol.188, issue.3, pp.1283-91, 2012.

E. Belnoue, M. Pihlgren, T. L. Mcgaha, C. Tougne, A. F. Rochat et al., APRIL is critical for plasmablast survival in the bone marrow and poorly expressed by early-life bone marrow stromal cells, Blood, vol.111, issue.5, pp.2755-64, 2008.

M. J. Benson, S. R. Dillon, E. Castigli, R. S. Geha, S. Xu et al., Cutting edge: the dependence of plasma cells and independence of memory B cells on BAFF and APRIL, J Immunol, vol.180, issue.6, pp.3655-3664, 2008.

C. Berek and H. J. Kim, B-cell activation and development within chronically inflamed synovium in rheumatoid and reactive arthritis, Semin Immunol, vol.9, issue.4, pp.261-269, 1997.

C. Berek, A. Berger, and M. Apel, Maturation of the immune response in germinal centers, Cell, vol.67, issue.6, pp.1121-1130, 1991.

F. Bergamin, I. E. Vincent, A. Summerfield, and K. C. Mccullough, Essential role of antigen-presenting cellderived BAFF for antibody responses, Eur J Immunol, vol.37, issue.11, pp.3122-3152, 2007.

P. A. Blair, L. Y. Noreña, F. Flores-borja, D. J. Rawlings, D. A. Isenberg et al., CD19(+) CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients, Immunity, vol.32, issue.1, pp.129-169, 2010.

A. Bolduc, E. Long, D. Stapler, M. Cascalho, T. Tsubata et al., Constitutive CD40L expression on B cells prematurely terminates germinal center response and leads to augmented plasma cell production in T cell areas, J Immunol, vol.185, issue.1, pp.220-250, 2010.

N. A. Bos, H. Kimura, C. G. Meeuwsen, D. Visser, H. Hazenberg et al., Serum immunoglobulin levels and naturally occurring antibodies against carbohydrate antigens in germ-free BALB/c mice fed chemically defined ultrafiltered diet, Eur J Immunol, vol.19, issue.12, pp.2335-2344, 1989.

D. T. Boumpas, R. Furie, S. Manzi, G. G. Illei, D. J. Wallace et al., Vaishnaw A; BG9588 Lupus Nephritis Trial Group. A short course of BG9588 (anti-CD40 ligand antibody) improves serologic activity and decreases hematuria in patients with proliferative lupus glomerulonephritis, Arthritis Rheum, vol.48, issue.3, pp.719-746, 2003.

G. Cambridge, D. A. Isenberg, J. C. Edwards, M. J. Leandro, T. S. Migone et al., B cell depletion therapy in systemic lupus erythematosus: relationships among serum B lymphocyte stimulator levels, autoantibody profile and clinical response, Ann Rheum Dis, vol.67, issue.7, pp.1011-1017, 2008.

G. Cambridge, M. J. Leandro, J. C. Edwards, M. R. Ehrenstein, M. Salden et al., Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis, Arthritis Rheum, vol.48, issue.8, pp.2146-54, 2003.

L. M. Carter, D. A. Isenberg, and M. R. Ehrenstein, Elevated serum BAFF levels are associated with rising antidouble-stranded DNA antibody levels and disease flare following B cell depletion therapy in systemic lupus erythematosus, Arthritis Rheum, vol.65, issue.10, pp.2672-2681, 2013.

R. Casellas, T. A. Shih, M. Kleinewietfeld, J. Rakonjac, D. Nemazee et al., Contribution of receptor editing to the antibody repertoire, Science, vol.291, issue.5508, pp.1541-1545, 2001.

G. Cassese, S. Arce, A. E. Hauser, K. Lehnert, B. Moewes et al., Plasma cell survival is mediated by synergistic effects of cytokines and adhesiondependent signals, J Immunol, vol.171, issue.4, pp.1684-90, 2003.

G. Cassese, S. Lindenau, B. De-boer, S. Arce, A. Hauser et al., Inflamed kidneys of NZB / W mice are a major site for the homeostasis of plasma cells, Eur J Immunol, vol.31, issue.9, pp.2726-2758, 2001.

E. Castigli, S. Scott, F. Dedeoglu, P. Bryce, H. Jabara et al., Impaired IgA class switching in APRIL-deficient mice, Proc Natl Acad Sci U S A, vol.101, issue.11, pp.3903-3911, 2004.

N. Chamberlain, C. Massad, T. Oe, T. Cantaert, K. C. Herold et al., Rituximab does not reset defective early B cell tolerance checkpoints, J Clin Invest, vol.126, issue.1, pp.282-289, 2016.

O. T. Chan, L. G. Hannum, A. M. Haberman, M. P. Madaio, and M. J. Shlomchik, A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus, J Exp Med, vol.189, issue.10, pp.1639-1687, 1999.

A. Chang, S. G. Henderson, D. Brandt, N. Liu, R. Guttikonda et al., In situ B cell-mediated immune responses and tubulointerstitial inflammation in human lupus nephritis, J Immunol, vol.186, issue.3, pp.1849-60, 2011.

G. S. Cheema, V. Roschke, D. M. Hilbert, and W. Stohl, Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases, Arthritis Rheum, vol.44, issue.6, pp.1313-1322, 2004.

Q. Cheng, I. M. Mumtaz, L. Khodadadi, A. Radbruch, B. F. Hoyer et al., Autoantibodies from long-lived 'memory' plasma cells of NZB/W mice drive immune complex nephritis, Ann Rheum Dis, vol.72, issue.12, pp.2011-2018, 2013.

I. Chernova, D. D. Jones, J. R. Wilmore, A. Bortnick, M. Yucel et al., Lasting antibody responses are mediated by a combination of newly formed and established bone marrow plasma cells drawn from clonally distinct precursors, J Immunol, vol.193, issue.10, pp.4971-4980, 2014.

S. Chevrier, D. Emslie, W. Shi, T. Kratina, C. Wellard et al., The BTB-ZF transcription factor Zbtb20 is driven by Irf4 to promote plasma cell differentiation and longevity, J Exp Med, vol.211, issue.5, pp.827-867, 2014.

S. Chevrier, C. Genton, A. Kallies, A. Karnowski, L. A. Otten et al., Acha-Orbea H. CD93 is required for maintenance of antibody secretion and persistence of plasma cells in the bone marrow niche, Proc Natl Acad Sci, vol.106, issue.10, pp.3895-900, 2009.

S. R. Christensen, J. Shupe, K. Nickerson, M. Kashgarian, R. A. Flavell et al., Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus, Immunity, vol.25, issue.3, pp.417-445, 2006.

V. T. Chu, A. Fröhlich, G. Steinhauser, T. Scheel, T. Roch et al., Eosinophils are required for the maintenance of plasma cells in the bone marrow, Nat Immunol, vol.12, issue.2, pp.151-160, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00613147

C. M. Coquery, W. M. Loo, N. S. Wade, A. G. Bederman, K. S. Tung et al., BAFF regulates follicular helper t cells and affects their accumulation and interferon-production in autoimmunity, Arthritis Rheumatol, vol.67, issue.3, pp.773-84, 2015.

C. M. Coquery, N. S. Wade, W. M. Loo, J. M. Kinchen, K. M. Cox et al., Neutrophils contribute to excess serum BAFF levels and promote CD4+ T cell and B cell responses in lupus-prone mice, PLoS One, vol.9, issue.7, p.102284, 2014.

D. Cornec, S. Costa, V. Devauchelle-pensec, J. , S. Marcorelles et al., Blood and salivary-gland BAFFdriven B-cell hyperactivity is associated to rituximab inefficacy in primary Sjögren's syndrome, J Autoimmun, vol.67, pp.102-112, 2016.

J. E. Craft, Follicular helper T cells in immunity and systemic autoimmunity, Nat Rev Rheumatol, vol.8, issue.6, pp.337-384, 2012.

S. Crotty, E. N. Kersh, J. Cannons, P. L. Schwartzberg, and R. Ahmed, SAP is required for generating long-term humoral immunity, Nature, vol.16, issue.6920, pp.282-289, 2003.

V. Devauchelle-pensec, M. X. Jousse-joulin, S. Berthelot, J. M. Perdriger, A. Puéchal et al., Treatment of primary Sjögren syndrome with rituximab: a randomized trial, Ann Intern Med, vol.160, issue.4, pp.233-275, 2014.

D. J. Dilillo, Y. Hamaguchi, Y. Ueda, K. Yang, J. Uchida et al., Maintenance of long-lived plasma cells and serological memory despite mature and memory B cell depletion during CD20 immunotherapy in mice, J Immunol, vol.180, issue.1, pp.361-71, 2008.

B. B. Ding, E. Bi, H. Chen, J. J. Yu, and B. H. Ye, IL-21 and CD40L synergistically promote plasma cell differentiation through upregulation of Blimp-1 in human B cells, J Immunol, vol.190, issue.4, pp.1827-1863, 2013.

I. Dogan, B. Bertocci, V. Vilmont, F. Delbos, J. Mégret et al., Multiple layers of B cell memory with different effector functions, Nat Immunol, vol.10, issue.12, pp.1292-1301, 2009.

T. Dörner, A. Shock, D. M. Goldenberg, and P. E. Lipsky, The mechanistic impact of CD22 engagement with epratuzumab on B cell function: Implications for the treatment of systemic lupus erythematosus, Autoimmun Rev, vol.14, issue.12, pp.1079-86, 2015.

J. C. Edwards, L. Szczepanski, J. Szechinski, A. Filipowicz-sosnowska, P. Emery et al., Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis, N Engl J Med, vol.350, issue.25, pp.2572-81, 2004.

M. R. Ehrenstein and C. Wing, The BAFFling effects of rituximab in lupus: danger ahead?, Nat Rev Rheumatol, vol.12, issue.6, pp.367-72, 2016.

J. I. Ellyard, D. T. Avery, C. R. Mackay, and S. G. Tangye, Contribution of stromal cells to the migration, function and retention of plasma cells in human spleen: potential roles of CXCL12, IL-6 and CD54, Eur J Immunol, vol.35, issue.3, pp.699-708, 2005.

P. Emery, W. Rigby, P. P. Tak, T. Dörner, E. Olech et al., Safety with ocrelizumab in rheumatoid arthritis: results from the ocrelizumab phase III program, PLoS One, vol.9, issue.2, p.87379, 2014.

M. Espeli, S. Bökers, G. Giannico, H. A. Dickinson, V. Bardsley et al., Local renal autoantibody production in lupus nephritis, J Am Soc Nephrol, vol.22, issue.2, pp.296-305, 2011.

S. Fagarasan and T. Honjo, Intestinal IgA synthesis: regulation of front-line body defences, Nat Rev Immunol, vol.3, issue.1, pp.63-72, 2003.

S. Fagarasan and T. Honjo, T-Independent immune response: new aspects of B cell biology, Science, vol.290, issue.5489, pp.89-92, 2000.

K. A. Fairfax, L. M. Corcoran, C. Pridans, N. D. Huntington, A. Kallies et al., Different kinetics of blimp-1 induction in B cell subsets revealed by reporter gene, J Immunol, vol.178, issue.7, pp.4104-4115, 2007.

W. A. Figgett, D. Deliyanti, K. A. Fairfax, P. S. Quah, J. L. Wilkinson-berka et al., Deleting the BAFF receptor TACI protects against systemic lupus erythematosus without extensive reduction of B cell numbers, J Autoimmun, vol.61, pp.9-16, 2015.

S. Fillatreau, C. H. Sweenie, M. J. Mcgeachy, D. Gray, and S. M. Anderton, B cells regulate autoimmunity by provision of IL-10, Nat Immunol, vol.3, issue.10, pp.944-50, 2002.

B. K. Finck, P. S. Linsley, and D. Wofsy, Treatment of murine lupus with CTLA4Ig, Science, vol.265, issue.5176, pp.1225-1232, 1994.

J. B. Foote, T. I. Mahmoud, A. M. Vale, and J. F. Kearney, Long-term maintenance of polysaccharide-specific antibodies by IgM-secreting cells, J Immunol, vol.188, issue.1, pp.57-67, 2012.

D. Foster, J. Parrish-novak, B. Fox, and W. Xu, Cytokine-receptor pairing: accelerating discovery of cytokine function, Nat Rev Drug Discov, vol.3, issue.2, pp.160-70, 2004.

R. Furie, M. Petri, O. Zamani, R. Cervera, D. J. Wallace et al., BLISS-76 Study Group. A phaseIII, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus, Arthritis Rheum, vol.63, issue.12, pp.3918-3948, 2011.

K. N. Ganjoo, S. De-vos, B. L. Pohlman, I. W. Flinn, A. Forero-torres et al., Phase 1/2 study of ocaratuzumab, an Fc-engineered humanized anti-CD20 monoclonal antibody, in low-affinity FcRIIIa patients with previously treated follicular lymphoma, Leuk Lymphoma, vol.56, issue.1, pp.42-50, 2015.

C. García-de-vinuesa, A. Gulbranson-judge, M. Khan, P. O'leary, M. Cascalho et al., Dendritic cells associated with plasmablast survival, Eur J Immunol, vol.29, issue.11, pp.3712-3733, 1999.

S. Gardam and R. Brink, Non-Canonical NF-?B Signaling Initiated by BAFF Influences B Cell Biology at Multiple Junctures. Front Immunol, vol.6, p.509, 2014.

D. Gay, T. Saunders, S. Camper, and M. Weigert, Receptor editing: an approach by autoreactive B cells to escape tolerance, J Exp Med, vol.177, issue.4, pp.999-1008, 1993.

M. C. Genovese, N. Kinnman, G. De-la-bourdonnaye, P. Rossi, C. Tak et al., Atacicept in patients with rheumatoid arthritis and an inadequate response to tumor necrosis factor antagonist therapy: results of a phase II, randomized,placebo-controlled, dose-finding trial, Arthritis Rheum, vol.63, issue.7, pp.1793-803, 2011.

N. V. Giltiay, C. P. Chappell, and E. A. Clark, B-cell selection and the development of autoantibodies, Arthritis Res Ther, vol.14, 2012.

E. M. Ginzler, S. Wax, A. Rajeswaran, S. Copt, J. Hillson et al., Atacicept in combination with MMF and corticosteroids in lupus nephritis: results of a prematurely terminated trial, Arthritis Res Ther, vol.14, issue.1, p.33, 2012.

R. Goenka, A. H. Matthews, B. Zhang, P. J. O'neill, J. L. Scholz et al., Local BLyS production by T follicular cells mediates retention of high affinity B cells during affinity maturation, J Exp Med, vol.211, issue.1, pp.45-56, 2014.

H. Gonda, M. Sugai, Y. Nambu, T. Katakai, Y. Agata et al., The balance between Pax5 and Id2 activities is the key to AID gene expression, J Exp Med, vol.198, issue.9, pp.1427-1464, 2003.

K. L. Good-jacobson, C. G. Szumilas, L. Chen, A. H. Sharpe, M. M. Tomayko et al., PD-1 regulates germinal center B cell survival and the formation and affinity of long-lived plasma cells, Nat Immunol, vol.11, issue.6, pp.535-577, 2010.

C. C. Goodnow, J. Sprent, F. De-st-groth, B. Vinuesa, and C. G. , Cellular and genetic mechanisms of self tolerance and autoimmunity, Nature, vol.435, issue.7042, pp.590-597, 2005.

J. Groom, S. L. Kalled, A. H. Cutler, C. Olson, S. A. Woodcock et al., Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren's syndrome, J Clin Invest, vol.109, issue.1, pp.59-68, 2002.

J. R. Groom, C. A. Fletcher, S. N. Walters, S. T. Grey, S. V. Watt et al., BAFF and MyD88 signals promote a lupuslike disease independent of T cells, J Exp Med, vol.204, issue.8, pp.1959-71, 2007.

J. A. Gross, S. R. Dillon, S. Mudri, J. Johnston, A. Littau et al., TACI-Ig neutralizes molecules critical for B cell development and autoimmune disease. impaired B cell maturation in mice lacking BLyS, Immunity, vol.15, issue.2, pp.289-302, 2001.

J. A. Gross, J. Johnston, S. Mudri, R. Enselman, S. R. Dillon et al., TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease, Nature, vol.404, issue.6781, pp.995-1004, 2000.

L. Guillevin, C. Pagnoux, A. Karras, C. Khouatra, O. Aumaître et al., Mouthon L; French Vasculitis Study Group. Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis, N Engl J Med, vol.371, pp.1771-80, 2014.

W. Guo, D. Smith, K. Aviszus, T. Detanico, R. A. Heiser et al., Somatic hypermutation as a generator of antinuclear antibodies in a murine model of systemic autoimmunity, J Exp Med, vol.207, issue.10, pp.2225-2262, 2010.

K. M. Haas, J. C. Poe, D. A. Steeber, and T. F. Tedder, B-1a and B-1b cells exhibit distinct developmental requirements and have unique functional roles in innate and adaptive immunity to S. pneumoniae, Immunity, vol.23, issue.1, pp.7-18, 2005.

J. L. Halliley, C. M. Tipton, J. Liesveld, A. F. Rosenberg, J. Darce et al., Long-Lived Plasma Cells Are Contained within the CD19(-)CD38(hi)CD138(+) Subset in Human Bone Marrow, Immunity, vol.43, issue.1, pp.132-177, 2015.

D. C. Hargreaves, P. L. Hyman, T. T. Lu, V. N. Ngo, A. Bidgol et al., A coordinated change in chemokine responsiveness guides plasma cell movements, J Exp Med, vol.194, issue.1, pp.45-56, 2001.

W. J. Harrington, V. Minnich, J. W. Hollingsworth, and C. V. Moore, Demonstration of a thrombocyto-penic factor in the blood of patients with thrombocytopenic purpura, J Lab Clin Med, vol.115, issue.5, pp.636-681, 1951.

H. Hase, Y. Kanno, M. Kojima, K. Hasegawa, D. Sakurai et al., BAFF/BLyS can potentiate B-cell selection with the B-cell coreceptor complex, Blood, vol.103, issue.6, pp.2257-65, 2004.

A. E. Hauser, G. F. Debes, S. Arce, G. Cassese, A. Hamann et al., Chemotactic responsiveness toward ligands for CXCR3 and CXCR4 is regulated on plasma blasts during the time course of a memory immune response, J Immunol, vol.169, issue.3, pp.1277-82, 2002.

K. Hayakawa, M. Asano, S. A. Shinton, M. Gui, D. Allman et al., Positive selection of natural autoreactive B cells, Science, vol.285, issue.5424, pp.113-119, 1999.

B. He, W. Xu, P. A. Santini, A. D. Polydorides, A. Chiu et al., Intestinal bacteria trigger T cell-independent immunoglobulin A(2) class switching by inducing epithelial-cell secretion of the cytokine APRIL, Immunity, vol.26, issue.6, pp.812-838, 2007.

N. Heise, D. Silva, N. S. Silva, K. Carette, A. Simonetti et al., Germinal center B cell maintenance and differentiation are controlled by distinct NF-?B transcription factor subunits, J Exp Med, vol.211, issue.10, pp.2103-2121, 2014.

M. Henneken, T. Dörner, G. R. Burmester, and C. Berek, Differential expression of chemokine receptors on peripheral blood B cells from patients with rheumatoid arthritis and systemic lupus erythematosus, Arthritis Res Ther, vol.7, issue.5, pp.1001-1014, 2005.

D. Herber, T. P. Brown, S. Liang, D. A. Young, M. Collins et al., IL-21 has a pathogenic role in a lupus-prone mouse model and its blockade with IL-21R.Fc reduces disease progression, J Immunol, vol.178, issue.6, pp.3822-3852, 2007.

F. Ho, J. E. Lortan, I. C. Maclennan, and M. Khan, Distinct short-lived and long-lived antibody-producing cell populations, Eur J Immunol, vol.16, issue.10, pp.1297-301, 1986.

F. A. Houssiau, J. P. Devogelaer, J. Van-damme, C. N. De-deuxchaisnes, V. Snick et al., Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides, Arthritis Rheum, vol.31, issue.6, pp.784-792, 1988.

B. F. Hoyer, K. Moser, A. E. Hauser, A. Peddinghaus, C. Voigt et al., Shortlived plasmablasts and long-lived plasma cells contribute to chronic humoral autoimmunity in NZB/W mice, J Exp Med, vol.199, issue.11, pp.1577-84, 2004.

K. Hozumi, N. Negishi, D. Suzuki, N. Abe, Y. Sotomaru et al., Delta-like 1 is necessary for the generation of marginal zone B cells but not T cells in vivo, Nat Immunol, vol.5, issue.6, pp.638-682, 2004.

M. C. Hsu, K. M. Toellner, C. G. Vinuesa, and I. C. Maclennan, B cell clones that sustain long-term plasmablast growth in T-independent extrafollicular antibody responses, Proc Natl Acad Sci, vol.103, issue.15, pp.5905-5915, 2006.

W. Huang, J. Sinha, J. Newman, B. Reddy, L. Budhai et al., The effect of anti-CD40 ligand antibody on B cells in human systemic lupus erythematosus, Arthritis Rheum, vol.46, issue.6, pp.1554-62, 2002.

B. Huard, T. Mckee, C. Bosshard, S. Durual, T. Matthes et al., APRIL secreted by neutrophils binds to heparan sulfate proteoglycans to create plasma cell niches in human mucosa, J Clin Invest, vol.118, issue.8, pp.2887-95, 2008.

B. Huard, L. Arlettaz, C. Ambrose, V. Kindler, D. Mauri et al., BAFF production by antigen-presenting cells provides T cell co-stimulation, Int Immunol, vol.16, issue.3, pp.467-75, 2004.

B. Huard, P. Schneider, D. Mauri, J. Tschopp, and L. E. French, T cell costimulation by the TNF ligand BAFF, J Immunol, vol.167, issue.11, p.957, 2001.

A. Hutloff, K. Büchner, K. Reiter, H. J. Baelde, M. Odendahl et al., Involvement of inducible costimulator in the exaggerated memory B cell and plasma cell generation in systemic lupus erythematosus, Arthritis Rheum, vol.50, issue.10, pp.3211-3231, 2004.

L. Hyland, M. Sangster, R. Sealy, and C. Coleclough, Respiratory virus infection of mice provokes a permanent humoral immune response, J Virol, vol.68, issue.9, pp.6083-6089, 1994.

K. Ingold, A. Zumsteg, A. Tardivel, B. Huard, Q. G. Steiner et al., Identification of proteoglycans as the APRILspecific binding partners, J Exp Med, vol.201, issue.9, pp.1375-83, 2005.

D. Isenberg, C. Gordon, D. Licu, S. Copt, C. P. Rossi et al., Efficacy and safety of atacicept for prevention of flares in patients with moderate-to-severe systemic lupus erythematosus (SLE): 52-week data (APRIL-SLE randomised trial), Ann Rheum Dis, vol.74, issue.11, pp.2006-2021, 2015.

D. A. Isenberg, M. Petri, K. Kalunian, Y. Tanaka, M. B. Urowitz et al., Efficacy and safety of subcutaneous tabalumab in patients with systemic lupus erythematosus: results from ILLUMINATE-1, a 52-week, phase III, multicentre, randomised, doubleblind,placebo-controlled study, Ann Rheum Dis, vol.75, issue.2, pp.323-354, 2016.

H. Iwai, M. Abe, S. Hirose, F. Tsushima, K. Tezuka et al., Involvement of inducible costimulator-B7 homologous protein costimulatory pathway in murine lupus nephritis, J Immunol, vol.171, issue.6, pp.2848-54, 2003.

N. N. Iwakoshi, A. H. Lee, and L. H. Glimcher, The X-box binding protein-1 transcription factor is required for plasma cell differentiation and the unfolded protein response, Immunol Rev, vol.194, pp.29-38, 2003.

H. M. Jacobs, C. D. Thouvenel, S. Leach, T. Arkatkar, G. Metzler et al., Cutting Edge: BAFF Promotes Autoantibody Production via TACI-Dependent Activation of Transitional B Cells, J Immunol, vol.196, issue.9, pp.3525-3556, 2016.

S. Jain, G. Park, T. J. Sproule, G. J. Christianson, C. M. Leeth et al., Interleukin 6 Accelerates Mortality by Promoting the Progression of the Systemic Lupus Erythematosus-Like Disease of BXSB.Yaa Mice, PLoS One, vol.11, issue.4, p.153059, 2016.

E. Jang, W. S. Cho, Y. K. Oh, M. L. Cho, J. M. Kim et al., Splenic Long-Lived Plasma Cells Promote the Development of Follicular Helper T Cells during Autoimmune Responses, J Immunol, vol.196, issue.3, pp.1026-1061, 2016.

E. Jang, W. S. Cho, M. L. Cho, H. J. Park, H. J. Oh et al., Foxp3+ regulatory T cells control humoral autoimmunity by suppressing the development of long-lived plasma cells, J Immunol, vol.186, issue.3, pp.1546-53, 2011.

M. Jourdan, M. Cren, N. Robert, K. Bolloré, T. Fest et al., IL-6 supports the generation of human long-lived plasma cells in combination with either APRIL or stromal cell-soluble factors, Leukemia, vol.28, issue.8, pp.1647-56, 2014.
URL : https://hal.archives-ouvertes.fr/hal-00974531

K. Kabashima, N. M. Haynes, Y. Xu, S. L. Nutt, M. L. Allende et al., Plasma cell S1P1 expression determines secondary lymphoid organ retention versus bone marrow tropism, J Exp Med, vol.203, issue.12, pp.2683-90, 2006.

A. Kallies, J. Hasbold, K. Fairfax, C. Pridans, D. Emslie et al., Initiation of plasma-cell differentiation is independent of the transcription factor Blimp-1, Immunity, vol.26, issue.5, pp.555-66, 2007.

A. Kallies, J. Hasbold, D. M. Tarlinton, W. Dietrich, L. M. Corcoran et al., Plasma cell ontogeny defined by quantitative changes in blimp-1expression, J Exp Med, vol.200, issue.8, pp.967-77, 2004.

K. C. Kalunian, J. C. Davis, J. T. Merrill, M. C. Totoritis, and D. Wofsy,

, Treatment of systemic lupus erythematosus by inhibition of T cell costimulation with anti-CD154: a randomized, double-blind, placebo-controlled trial, Arthritis Rheum, vol.46, issue.12, pp.3251-3259, 2002.

T. Kawabe, T. Naka, K. Yoshida, T. Tanaka, H. Fujiwara et al., The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation, Immunity, vol.1, issue.3, pp.167-78, 1994.

K. A. Keogh, M. E. Wylam, J. H. Stone, and U. Specks, Induction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody-associated vasculitis, Arthritis Rheum, vol.52, issue.1, pp.262-270, 2005.

S. D. Khare, I. Sarosi, X. Z. Xia, S. Mccabe, K. Miner et al., Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice, Proc Natl Acad Sci, vol.97, issue.7, pp.3370-3375, 2000.

M. Khellaf, A. Charles-nelson, O. Fain, L. Terriou, J. F. Viallard et al., Safety and efficacy of rituximab in adult immune thrombocytopenia: results from a prospective registry including 248 patients, Blood, vol.124, issue.22, pp.3228-3264, 2014.

L. Khodadadi, Q. Cheng, T. Alexander, Ö. Sercan-alp, J. Klotsche et al., Bortezomib Plus Continuous B Cell Depletion Results in Sustained Plasma Cell Depletion and Amelioration of Lupus Nephritis in NZB/W F1 Mice, PLoS One, vol.10, issue.8, p.135081, 2015.

H. J. Kim and C. Berek, B cells in rheumatoid arthritis, Arthritis Res, vol.2, issue.2, pp.126-157, 2000.

H. J. Kim, V. Krenn, G. Steinhauser, and C. Berek, Plasma cell development in synovial germinal centers in patients with rheumatoid and reactive arthritis, J Immunol, vol.162, issue.5, pp.3053-62, 1999.

Y. Kishi, Y. Aiba, T. Higuchi, K. Furukawa, T. Tokuhisa et al., Augmented antibody response with premature germinal center regression in CD40L transgenic mice, J Immunol, vol.185, issue.1, pp.211-220, 2010.

U. Klein, S. Casola, G. Cattoretti, Q. Shen, M. Lia et al., Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination, Nat Immunol, vol.7, issue.7, pp.773-82, 2006.

T. Kraaij, T. W. Huizinga, T. J. Rabelink, and Y. K. Teng, Belimumab after rituximab as maintenance therapy in lupus nephritis, Rheumatology (Oxford), vol.53, issue.11, pp.2122-2126, 2014.

M. Kraus, M. B. Alimzhanov, N. Rajewsky, and K. Rajewsky, Survival of resting mature B lymphocytes depends on BCR signaling via the Igalpha/beta heterodimer, Cell, vol.117, issue.6, pp.787-800, 2004.

S. Lacotte, M. Decossas, L. Coz, C. Brun, S. Muller et al., Early differentiated CD138 (high) MHCII+ IgG+ plasma cells express CXCR3 and localize into inflamed kidneys of lupus mice, PLoS One, vol.8, issue.3, p.58140, 2013.

F. Lavie, C. Miceli-richard, M. Ittah, J. Sellam, J. E. Gottenberg et al., Increase of B cell-activating factor of the TNF family (BAFF) after rituximab treatment: insights into a new regulating system of BAFF production, Ann Rheum Dis, vol.66, issue.5, pp.700-703, 2007.

F. Lavie, C. Miceli-richard, J. Quillard, S. Roux, P. Leclerc et al., Expression of BAFF (BLyS) in T cells infiltrating labial salivary glands from patients with Sjögren's syndrome, J Pathol, vol.202, issue.4, pp.496-502, 2004.

M. J. Leandro, G. Cambridge, M. R. Ehrenstein, and J. C. Edwards, Reconstitution of peripheral blood B cells after depletion with rituximab in patients with rheumatoid arthritis, Arthritis Rheum, vol.54, issue.2, pp.613-633, 2006.

M. J. Leandro, J. C. Edwards, G. Cambridge, M. R. Ehrenstein, and D. A. Isenberg, An open study of B lymphocyte depletion in systemic lupus erythematosus, Arthritis Rheum, vol.46, issue.10, pp.2673-2680, 2002.

R. Lesley, Y. Xu, S. L. Kalled, D. M. Hess, S. R. Schwab et al., Reduced competitiveness of autoantigen-engaged B cells due to increased dependence on BAFF, Immunity, vol.20, issue.4, pp.441-53, 2004.

L. Lin, A. J. Gerth, and S. L. Peng, Active inhibition of plasma cell development in resting B cells by microphthalmia-associated transcription factor, J Exp Med, vol.200, issue.1, pp.115-137, 2004.

W. Lin, D. Seshasayee, W. P. Lee, P. Caplazi, S. Mcvay et al., Dual B cell immunotherapy is superior to individual anti-CD20 depletion or BAFF blockade in murine models of spontaneous or accelerated lupus, Arthritis Rheumatol, vol.67, issue.1, pp.215-239, 2015.

Y. Lin, K. Wong, and K. Calame, Repression of c-myc transcription by Blimp-1, an inducer of terminal B cell differentiation, Science, vol.276, issue.5312, pp.596-605, 1997.

C. Lindner, I. Thomsen, B. Wahl, M. Ugur, M. K. Sethi et al., Diversification of memory B cells drives the continuous adaptation of secretory antibodies to gut microbiota, Nat Immunol, vol.16, issue.8, pp.880-888, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01604354

M. A. Linterman, L. Beaton, D. Yu, R. R. Ramiscal, M. Srivastava et al., IL-21 acts directly on B cells to regulate Bcl-6 expression and germinal center responses, J Exp Med, vol.207, issue.2, pp.353-63, 2010.

M. A. Linterman, R. J. Rigby, R. K. Wong, D. Yu, R. Brink et al., Follicular helper T cells are required for systemic autoimmunity, J Exp Med, vol.206, issue.3, pp.561-76, 2009.

M. B. Litinskiy, B. Nardelli, D. M. Hilbert, B. He, A. Schaffer et al., DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL, Nat Immunol, vol.3, issue.9, pp.822-831, 2002.

F. Loder, B. Mutschler, R. J. Ray, C. J. Paige, P. Sideras et al., B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals, J Exp Med, vol.190, issue.1, pp.75-89, 1999.

R. J. Looney, J. H. Anolik, D. Campbell, R. E. Felgar, F. Young et al., B cell depletion as a novel treatment for systemic lupus erythematosus: a phase I/II dose-escalation trial of rituximab, Arthritis Rheum, vol.50, issue.8, pp.2580-2589, 2004.

F. Mackay and H. Leung, The role of the BAFF/APRIL system on T cell function, Semin Immunol, vol.18, issue.5, pp.284-293, 2006.

F. Mackay, S. A. Woodcock, P. Lawton, C. Ambrose, M. Baetscher et al., Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations, J Exp Med, vol.190, issue.11, pp.1697-710, 1999.

I. Maclennan and C. Vinuesa, Dendritic cells, BAFF, and APRIL: innate players in adaptive antibody responses, Immunity, vol.17, issue.3, pp.235-243, 2002.

I. C. Maclennan, K. M. Toellner, A. F. Cunningham, K. Serre, D. M. Sze et al., Extrafollicular antibody responses, Immunol Rev, vol.194, pp.8-18, 2003.

A. J. Macpherson, D. Gatto, E. Sainsbury, G. R. Harriman, H. Hengartner et al., A primitive T cellindependent mechanism of intestinal mucosal IgA responses to commensal bacteria, Science, vol.288, issue.5474, pp.2222-2228, 2000.

M. Mahévas, M. Michel, B. Vingert, J. Moroch, D. Boutboul et al., Emergence of long-lived autoreactive plasma cells in the spleen of primary warm auto-immune hemolytic anemia patients treated with rituximab, J Autoimmun, vol.62, pp.22-30, 2015.

M. Mahévas, P. Patin, F. Huetz, M. Descatoire, N. Cagnard et al., B cell depletion in immune thrombocytopenia reveals splenic long-lived plasma cells, J Clin Invest, vol.123, issue.1, pp.432-474, 2013.

R. A. Manz, M. Löhning, G. Cassese, A. Thiel, and A. Radbruch, Survival of long-lived plasma cells is independent of antigen, Int Immunol, vol.10, issue.11, pp.1703-1714, 1998.

R. A. Manz, A. Thiel, and A. Radbruch, Lifetime of plasma cells in the bone marrow, Nature, vol.388, issue.6638, pp.133-137, 1997.

S. Manzi, J. Sánchez-guerrero, J. T. Merrill, R. Furie, D. Gladman et al., BLISS-52 and BLISS-76 Study Groups. Effects of belimumab, a B lymphocyte stimulator-specific inhibitor, on disease activity across multiple organ domains in patients with systemic lupus erythematosus: combined results from two phase III trials, Ann Rheum Dis, vol.71, issue.11, pp.1833-1841, 2012.

X. Mariette, R. Seror, L. Quartuccio, G. Baron, S. Salvin et al., Efficacy and safety of belimumab in primary Sjögren's syndrome: results of the BELISS openlabel phase II study, Ann Rheum Dis, vol.74, issue.3, pp.526-557, 2015.

F. Martin and A. C. Chan, Pathogenic roles of B cells in human autoimmunity; insights from the clinic, Immunity, vol.20, issue.5, pp.517-544, 2004.

F. Martin and J. F. Kearney, Marginal-zone B cells, Nat Rev Immunol, vol.2, issue.5, pp.323-358, 2002.

F. Martin, A. M. Oliver, and J. F. Kearney, Marginal zone and B1 B cells unite in the early response against Tindependent blood-borne particulate antigens, Immunity, vol.14, issue.5, pp.617-646, 2001.

M. Maruyama, K. P. Lam, and K. Rajewsky, Memory B-cell persistence is independent of persisting immunizing antigen, Nature, vol.407, issue.6804, pp.636-678, 2000.

M. Matsumoto, S. F. Lo, C. J. Carruthers, J. Min, S. Mariathasan et al., Affinity maturation without germinal centres in lymphotoxin-alpha-deficient mice, Nature, vol.382, issue.6590, pp.462-468, 1996.

T. Matthes, I. Dunand-sauthier, M. L. Santiago-raber, K. H. Krause, O. Donze et al., Production of the plasma-cell survival factor a proliferation-inducing ligand (APRIL) peaks in myeloid precursor cells from human bone marrow, Blood, vol.118, issue.7, pp.1838-1882, 2011.

C. Mauri, D. Gray, N. Mushtaq, and M. Londei, Prevention of arthritis by interleukin 10-producing B cells, J Exp Med, vol.197, issue.4, pp.489-501, 2003.

P. Mclaughlin, A. J. Grillo-lópez, B. K. Link, R. Levy, M. S. Czuczman et al., Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program, J Clin Oncol, vol.16, issue.8, pp.2825-2858, 1998.

M. Yusof, M. Y. Vital, E. M. Das, S. Dass, S. Arumugakani et al., Repeat cycles of rituximab on clinical relapse in ANCA-associated vasculitis: identifying B cell biomarkers for relapse to guide retreatment decisions, Ann Rheum Dis, vol.74, issue.9, pp.1734-1742, 2015.

F. Medina, C. Segundo, A. Campos-caro, I. González-garcía, and J. A. Brieva, The heterogeneity shown by human plasma cells from tonsil, blood, and bone marrow reveals graded stages of increasing maturity, but local profiles of adhesion molecule expression, Blood, vol.99, issue.6, pp.2154-61, 2002.

F. Medina, C. Segundo, C. Rodríguez, and J. A. Brieva, Regulatory role of CD95 ligation on human B cells induced in vivo capable of spontaneous and high-rate Ig secretion, Eur J Immunol, vol.27, issue.3, pp.700-706, 1997.

H. E. Mei, I. Wirries, D. Frölich, M. Brisslert, C. Giesecke et al., A unique population of IgG-expressing plasma cells lacking CD19 is enriched in human bone marrow, Blood, vol.125, issue.11, pp.1739-1787, 2015.

M. Menon, P. A. Blair, D. A. Isenberg, and C. Mauri, A Regulatory Feedback between Plasmacytoid Dendritic Cells and Regulatory B Cells Is Aberrant in Systemic Lupus Erythematosus, Immunity, vol.44, issue.3, pp.683-97, 2016.

J. T. Merrill, R. F. Van-vollenhoven, J. P. Buyon, R. A. Furie, W. Stohl et al., Efficacy and safety of subcutaneous tabalumab, a monoclonal antibody to B-cell activating factor, in patients with systemic lupus erythematosus: results from ILLUMINATE-2, a 52-week,phase III, multicentre, randomized, double-blind, placebo-controlled study, Ann Rheum Dis, vol.75, issue.2, pp.332-372, 2016.

J. T. Merrill, C. M. Neuwelt, D. J. Wallace, J. C. Shanahan, K. M. Latinis et al., Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial, Arthritis Rheum, vol.62, issue.1, pp.222-255, 2010.

P. Merville, J. Déchanet, A. Desmoulière, I. Durand, O. De-bouteiller et al., Bcl-2+ tonsillar plasma cells are rescued from apoptosis by bone marrow fibroblasts, J Exp Med, vol.183, issue.1, pp.227-263, 1996.

M. Mihara, I. Tan, Y. Chuzhin, B. Reddy, L. Budhai et al., CTLA4Ig inhibits T celldependent B-cell maturation in murine systemic lupus erythematosus, J Clin Invest, vol.106, issue.1, pp.91-101, 2000.

H. A. Minges-wols, G. H. Underhill, G. S. Kansas, and P. L. Witte, The role of bone marrow-derived stromal cells in the maintenance of plasma cell longevity, JImmunol, vol.169, issue.8, pp.4213-4234, 2002.

A. Mizoguchi, E. Mizoguchi, H. Takedatsu, R. S. Blumberg, and A. K. Bhan, Chronic intestina inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation, Immunity, vol.16, issue.2, pp.219-249, 2002.

C. Mohan, Y. Shi, J. D. Laman, and S. K. Datta, Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis, J Immunol, vol.154, issue.3, pp.1470-80, 1995.

E. Mohr, K. Serre, R. A. Manz, A. F. Cunningham, M. Khan et al., Dendritic cells and monocyte/macrophages that create the IL-6/APRIL-rich lymph node microenvironments where plasmablasts mature, J Immunol, vol.182, issue.4, pp.2113-2136, 2009.

E. Montecino-rodriguez, H. Leathers, and K. Dorshkind, Identification of a B-1 B cell-specified progenitor, Nat Immunol, vol.7, issue.3, pp.293-301, 2006.

G. Moroni, B. Gallelli, R. A. Sinico, G. Romano, L. Sinigaglia et al., Rituximab versus oral cyclophosphamide for treatment of relapses of proliferative lupus nephritis: a clinical observational study, Ann Rheum Dis, vol.71, issue.10, pp.1751-1753, 2012.

N. Moulian, S. Berrih-aknin, and . Fas, APO-1/CD95 in health and autoimmune disease: thymic and peripheral aspects, Semin Immunol, vol.10, issue.6, pp.449-56, 1998.

I. M. Mumtaz, B. F. Hoyer, D. Panne, K. Moser, O. Winter et al., Bone marrow of NZB/W mice is the major site for plasma cells resistant to dexamethasone and cyclophosphamide: implications for the treatment of autoimmunity, J Autoimmun, vol.39, issue.3, pp.180-188, 2012.

M. Muramatsu, K. Kinoshita, S. Fagarasan, S. Yamada, Y. Shinkai et al., Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme, Cell, vol.102, issue.5, pp.553-63, 2000.

A. Muto, S. Tashiro, O. Nakajima, H. Hoshino, S. Takahashi et al., The transcriptional programme of antibody class switching involves the repressor Bach2, Nature, vol.429, issue.6991, pp.566-71, 2004.

E. F. Mysler, A. J. Spindler, R. Guzman, M. Bijl, J. D. Furie et al., Efficacy and safety of ocrelizumab in active proliferative lupus nephritis: results from a randomized, double-blind, phase IIIstudy, Arthritis Rheum, vol.65, issue.9, pp.2368-79, 2013.

S. Nagata, Human autoimmune lymphoproliferative syndrome, a defect in the apoptosis-inducing Fas receptor: a lesson from the mouse model, J Hum Genet, vol.43, issue.1, pp.2-8, 1998.

S. V. Navarra, R. M. Guzmán, A. E. Gallacher, S. Hall, R. A. Levy et al.,

S. Group, Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised,placebo-controlled, phase 3 trial, Lancet, vol.377, issue.9767, pp.721-752, 2011.

D. A. Nemazee and K. Bürki, Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes, Nature, vol.337, issue.6207, pp.562-568, 1989.

K. P. Nera, P. Kohonen, E. Narvi, A. Peippo, L. Mustonen et al., Loss of Pax5 promotes plasma cell differentiation, Immunity, vol.24, issue.3, pp.283-93, 2006.

K. Neubert, S. Meister, K. Moser, F. Weisel, D. Maseda et al., The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis, Nat Med, vol.14, issue.7, pp.748-55, 2008.

K. P. Ng, G. Cambridge, M. J. Leandro, J. C. Edwards, M. Ehrenstein et al., B cell depletion therapy in systemic lupus erythematosus: long-term follow-up and predictors of response, Ann Rheum Dis, vol.66, issue.9, pp.1259-62, 2007.

L. G. Ng, C. R. Mackay, and F. Mackay, The BAFF/APRIL system: life beyond B lymphocytes, vol.42, pp.763-72, 2005.

L. G. Ng, A. P. Sutherland, R. Newton, F. Qian, T. G. Cachero et al., B cell-activating factor belonging to the TNF family (BAFF)-R is the principal BAFF receptor facilitating BAFF costimulation of circulating T and B cells, J Immunol, vol.173, issue.2, pp.807-824, 2004.

S. L. Nutt, K. A. Fairfax, and A. Kallies, BLIMP1 guides the fate of effector B and Tcells, Nat Rev Immunol, vol.7, issue.12, pp.923-930, 2007.

S. L. Nutt, D. Eberhard, M. Horcher, A. G. Rolink, and M. Busslinger, Pax5 determines the identity of B cells from the beginning to the end of B-lymphopoiesis, Int Rev Immunol, vol.20, issue.1, pp.65-82, 2001.

B. P. O'connor, V. S. Raman, L. D. Erickson, W. J. Cook, L. K. Weaver et al., BCMA is essential for the survival of long-lived bone marrow plasma cells, J Exp Med, vol.199, issue.1, pp.91-99, 2004.

K. Ochiai, A. Muto, H. Tanaka, S. Takahashi, and K. Igarashi, Regulation of the plasma cell transcription factor Blimp-1 gene by Bach2 and Bcl6, Int Immunol, vol.20, issue.3, pp.453-60, 2008.

A. F. Ochsenbein, T. Fehr, C. Lutz, M. Suter, F. Brombacher et al., Control of early viral and bacterial distribution and disease by natural antibodies, Science, vol.286, issue.5447, pp.2156-2165, 1999.

M. Odendahl, H. Mei, B. F. Hoyer, A. M. Jacobi, A. Hansen et al., Generation of migratory antigen-specific plasma blasts and mobilization of resident plasma cells in a secondary immune response, Blood, vol.105, issue.4, pp.1614-1635, 2005.

K. Ozaki, R. Spolski, R. Ettinger, H. P. Kim, G. Wang et al., Regulation of B cell differentiation and plasma cell generation by IL-21, a novel inducer of Blimp-1 and Bcl-6, J Immunol, vol.173, issue.9, pp.5361-71, 2004.

K. Ozaki, R. Spolski, C. G. Feng, C. F. Qi, J. Cheng et al., A critical role for IL-21 in regulating immunoglobulin production, Science, vol.298, issue.5598, pp.1630-1634, 2002.

O. Pabst, T. Peters, N. Czeloth, G. Bernhardt, K. Scharffetter-kochanek et al., Cutting edge: egress of newly generated plasma cells from peripheral lymph nodes depends on beta 2 integrin, J Immunol, vol.174, issue.12, pp.7492-7497, 2005.

O. Pabst, L. Ohl, M. Wendland, M. A. Wurbel, E. Kremmer et al., Chemokine receptor CCR9 contributes to the localization of plasma cells to the small intestine, J Exp Med, vol.199, issue.3, pp.411-417, 2004.

C. J. Patriquin, M. R. Thomas, T. Dutt, S. Mcguckin, P. A. Blombery et al., Bortezomib in the treatment of refractory thrombotic thrombocytopenic purpura, Br J Haematol, vol.173, issue.5, pp.779-85, 2016.

N. Pelletier, L. J. Mcheyzer-williams, K. A. Wong, E. Urich, N. Fazilleau et al., Plasma cells negatively regulate the follicular helper T cell program, Nat Immunol, vol.11, issue.12, pp.1110-1118, 2010.

N. Pelletier, M. Casamayor-pallejà, D. Luca, K. Mondière, P. Saltel et al., The endoplasmic reticulum is a key component of the plasma cell death pathway, J Immunol, vol.176, issue.3, pp.1340-1347, 2006.

N. Pengo, M. Scolari, L. Oliva, E. Milan, F. Mainoldi et al., Plasma cells require autophagy for sustainable immunoglobulin production, Nat Immunol, vol.14, issue.3, pp.298-305, 2013.

V. Peperzak, I. Vikström, J. Walker, S. P. Glaser, M. Lepage et al., Mcl-1 is essential for the survival of plasma cells, Nat Immunol, vol.14, issue.3, pp.290-297, 2013.

J. P. Pereira, L. M. Kelly, Y. Xu, and J. G. Cyster, EBI2 mediates B cell segregation between the outer and centre follicle, Nature, vol.460, issue.7259, pp.1122-1128, 2009.

M. D. Pescovitz, Rituximab, an anti-cd20 monoclonal antibody: history and mechanism of action, Am J Transplant, vol.6, issue.5, pp.859-66, 2006.

A. L. Peters, L. L. Stunz, and G. A. Bishop, CD40 and autoimmunity: the dark side of a great activator, Semin Immunol, vol.21, issue.5, pp.293-300, 2009.

T. G. Phan, D. Paus, T. D. Chan, M. L. Turner, S. L. Nutt et al., High affinity germinal center B cells are actively selected into the plasma cell compartment, J Exp Med, vol.203, issue.11, pp.2419-2443, 2006.

T. G. Phan, S. Gardam, A. Basten, and R. Brink, Altered migration, recruitment, and somatic hypermutation in the early response of marginal zone B cells to Tcell-dependent antigen, J Immunol, vol.174, issue.8, pp.4567-78, 2005.

I. Puga, M. Cols, C. M. Barra, B. He, L. Cassis et al., B cell-helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen, Nat Immunol, vol.13, issue.2, pp.170-80, 2011.

A. Radbruch, G. Muehlinghaus, E. O. Luger, A. Inamine, K. G. Smith et al., Competence and competition: the challenge of becoming a long-lived plasma cell, Nat Rev Immunol, vol.6, issue.10, pp.741-50, 2006.

Z. S. Rahman, S. P. Rao, S. L. Kalled, and T. Manser, Normal induction but attenuated progression of germinal center responses in BAFF and BAFF-R signaling-deficient mice, J Exp Med, vol.198, issue.8, pp.1157-69, 2003.

A. Ramos-amaya, B. Rodríguez-bayona, R. López-blanco, E. Andújar, M. Pérez-alegre et al., Survival of human circulating antigen-induced plasma cells is supported by plasma cellniche cytokines and T follicular helper lymphocytes, J Immunol, vol.194, issue.3, pp.1031-1039, 2015.

A. M. Reimold, N. N. Iwakoshi, J. Manis, P. Vallabhajosyula, E. Szomolanyi-tsuda et al., Plasma cell differentiation requires the transcription factor XBP-1, Nature, vol.412, issue.6844, pp.300-307, 2001.

W. Rigby, H. P. Tony, K. Oelke, B. Combe, A. Laster et al., Safety and efficacy of ocrelizumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a forty-eight-week randomized, double-blind, placebocontrolled, parallel-group phase III trial, Arthritis Rheum, vol.64, issue.2, pp.350-359, 2012.

R. Gomez, M. Talke, Y. Goebel, N. Hermann, F. Reich et al., Basophils support the survival of plasma cells in mice, J Immunol, vol.185, issue.12, pp.7180-7185, 2010.

B. Rodríguez-bayona, A. Ramos-amaya, R. López-blanco, A. Campos-caro, and J. A. Brieva, STAT-3 activation by differential cytokines is critical for human in vivo-generated plasma cell survival and Ig secretion, J Immunol, vol.191, issue.10, pp.4996-5004, 2013.

P. Roll, A. Palanichamy, C. Kneitz, T. Dorner, and H. P. Tony, Regeneration of B cell subsets after transient B cell depletion using anti-CD20 antibodies in rheumatoid arthritis, Arthritis Rheum, vol.54, issue.8, pp.2377-86, 2006.

B. H. Rovin, R. Furie, K. Latinis, R. J. Looney, F. C. Fervenza et al., LUNAR Investigator Group. Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the Lupus Nephritis Assessment with Rituximab study, Arthritis Rheum, vol.64, issue.4, pp.1215-1241, 2012.

C. H. Rozanski, R. Arens, L. M. Carlson, J. Nair, L. H. Boise et al., Sustained antibody responses depend on CD28 function in bone marrow-resident plasma cells, J Exp Med, vol.208, issue.7, pp.1435-1481, 2011.

S. Salomonsson, P. Larsson, P. Tengnér, E. Mellquist, P. Hjelmström et al., Expression of the B cell-attracting chemokine CXCL13 in the target organ and autoantibody production in ectopic lymphoid tissue in the chronic inflammatory disease Sjögren's syndrome, Scand J Immunol, vol.55, issue.4, pp.336-378, 2002.

A. Schebesta, S. Mcmanus, G. Salvagiotto, A. Delogu, G. A. Busslinger et al., Transcription factor Pax5 activates the chromatin of key genes involved in B cell signaling, adhesion, migration, and immune function, Immunity, vol.27, issue.1, pp.49-63, 2007.

J. L. Scholz, J. E. Crowley, M. M. Tomayko, N. Steinel, P. J. O'neill et al., BLyS inhibition eliminates primary B cells but leaves natural and acquired humoral immunity intact, Proc Natl Acad Sci, vol.105, issue.40, pp.15517-15539, 2008.

S. R. Schwab and J. G. Cyster, Finding a way out: lymphocyte egress from lymphoid organs, Nat Immunol, vol.8, issue.12, pp.1295-301, 2007.

R. Sciammas, A. L. Shaffer, J. H. Schatz, H. Zhao, L. M. Staudt et al., Graded expression of interferon regulatory factor-4 coordinates isotype switching with plasma cell differentiation, Immunity, vol.25, issue.2, pp.225-261, 2006.

R. Sciammas and M. M. Davis, Modular nature of Blimp-1 in the regulation of gene expression during B cell maturation, J Immunol, vol.172, issue.9, pp.5427-5467, 2004.

D. Seshasayee, P. Valdez, M. Yan, V. M. Dixit, D. Tumas et al., Loss of TACI causes fatal lymphoproliferation and autoimmunity, establishing TACI as an inhibitory BLyS receptor, Immunity, vol.18, issue.2, pp.279-88, 2003.

P. P. Sfikakis, J. N. Boletis, S. Lionaki, V. Vigklis, K. G. Fragiadaki et al., Remission of proliferative lupus nephritis following B cell depletion therapy is preceded by down-regulation of the T cell costimulatory molecule CD40 ligand: an open-label trial, Arthritis Rheum, vol.52, issue.2, pp.501-514, 2005.

A. L. Shaffer, K. I. Lin, T. C. Kuo, X. Yu, E. M. Hurt et al., Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program, Immunity, vol.17, issue.1, pp.51-62, 2002.

M. Shapiro-shelef and K. Calame, Regulation of plasma-cell development, Nat Rev Immunol. 2005 a, vol.5, issue.3, pp.230-272

M. Shapiro-shelef, K. I. Lin, D. Savitsky, J. Liao, and K. Calame, Blimp-1 is required for maintenance of longlived plasma cells in the bone marrow, J Exp Med. 2005 b, vol.202, issue.11, pp.1471-1477

M. Shapiro-shelef, K. I. Lin, L. J. Mcheyzer-williams, J. Liao, M. G. Mcheyzer-williams et al., Blimp-1 is required for the formation of immunoglobulin secreting plasma cells and pre-plasma memory B cells, Immunity, vol.19, issue.4, pp.607-627, 2003.

W. Shi, Y. Liao, S. N. Willis, N. Taubenheim, M. Inouye et al., Transcriptional profiling of mouse B cell terminal differentiation defines a signature for antibody-secreting plasma cells, Nat Immunol, vol.16, issue.6, pp.663-73, 2015.

N. Simpson, P. A. Gatenby, A. Wilson, S. Malik, D. A. Fulcher et al., Expansion of circulating T cells resembling follicular helper T cells is a fixed phenotype that identifies a subset of severe systemic lupus erythematosus, Arthritis Rheum, vol.62, issue.1, pp.234-278, 2010.

M. K. Slifka, R. Antia, J. K. Whitmire, and R. Ahmed, Humoral immunity due to long-lived plasma cells, Immunity, vol.8, issue.3, pp.363-72, 1998.

M. K. Slifka, M. Matloubian, and R. Ahmed, Bone marrow is a major site of long-term antibody production after acute viral infection, J Virol, vol.69, issue.3, pp.1895-902, 1995.

T. Slocombe, S. Brown, K. Miles, M. Gray, T. A. Barr et al., Plasma cell homeostasis: the effects of chronic antigen stimulation and inflammation, J Immunol, vol.191, issue.6, pp.3128-3166, 2013.

K. G. Smith, A. Light, L. A. O'reilly, S. M. Ang, A. Strasser et al., bcl-2 transgene expression inhibits apoptosis in the germinal center and reveals differences in the selection of memory B cells and bone marrow antibody-forming cells, J Exp Med, vol.191, issue.3, pp.475-84, 2000.

K. G. Smith, A. Light, G. J. Nossal, and D. M. Tarlinton, The extent of affinity maturation differs between the memory and antibody-forming cell compartments in the primary immune response, EMBO J, vol.16, issue.11, pp.2996-3006, 1997.

K. G. Smith, T. D. Hewitson, G. J. Nossal, and D. M. Tarlinton, The phenotype and fate of the antibody-forming cells of the splenic foci, Eur J Immunol, vol.26, issue.2, pp.444-452, 1996.

J. S. Smolen, M. E. Weinblatt, D. Van-der-heijde, W. F. Rigby, R. Van-vollenhoven et al., Efficacy and safety of tabalumab, an anti-B-cell-activating factor monoclonal antibody, in patients with rheumatoid arthritis who had an inadequate response to methotrexate therapy: results from a phase III multicentre,randomised, double-blind study, Ann Rheum Dis, vol.74, issue.8, pp.1567-70, 2015.

C. Starke, S. Frey, U. Wellmann, V. Urbonaviciute, M. Herrmann et al., High frequency of autoantibody-secreting cells and long-lived plasma cells within inflamed kidneys of NZB/W F1 lupus mice, Eur J Immunol, vol.41, issue.7, pp.2107-2119, 2011.

R. Stasi, A. Pagano, E. Stipa, and S. Amadori, Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura, Blood, vol.98, issue.4, pp.952-959, 2001.

W. Stohl, J. T. Merrill, J. D. Mckay, J. R. Lisse, Z. J. Zhong et al., Efficacy and safety of belimumab in patients with rheumatoid arthritis: a phase II, randomized, double-blind, placebocontrolled, dose-ranging Study, J Rheumatol, vol.40, issue.5, pp.579-89, 2013.

W. Stohl, S. Metyas, S. M. Tan, G. S. Cheema, B. Oamar et al., B lymphocyte stimulator overexpression in patients with systemic lupus erythematosus: longitudinal observations, Arthritis Rheum, vol.48, issue.12, pp.3475-86, 2003.

J. H. Stone, P. A. Merkel, R. Spiera, P. Seo, C. A. Langford et al., Rituximab versus cyclophosphamide for ANCA-associated vasculitis, N Engl J Med, vol.363, issue.3, pp.221-253, 2010.

D. I. Stott, F. Hiepe, M. Hummel, G. Steinhauser, and C. Berek, Antigen-driven clonal proliferation of B cells within the target tissue of an autoimmune disease. Thesalivary glands of patients with Sjögren's syndrome, J Clin Invest, vol.102, issue.5, pp.938-984, 1998.

A. Strasser and P. Bouillet, The control of apoptosis in lymphocyte selection, Immunol Rev, vol.193, pp.82-92, 2003.

S. Suematsu, T. Matsusaka, T. Matsuda, S. Ohno, J. Miyazaki et al., Generation of plasmacytomas with the chromosomal translocation t(12;15) in interleukin 6 transgenic mice, Proc Natl Acad Sci, vol.89, issue.1, pp.232-237, 1992.

A. P. Sutherland, L. G. Ng, C. A. Fletcher, B. Shum, R. A. Newton et al., BAFF augments certain Th1-associated inflammatory responses, J Immunol, vol.174, issue.9, pp.5537-5581, 2005.

D. M. Sze, K. M. Toellner, G. De-vinuesa, C. Taylor, D. R. Maclennan et al., Intrinsic constraint on plasmablast growth and extrinsic limits of plasma cell survival, J Exp Med, vol.192, issue.6, pp.813-834, 2000.

A. Taddeo, L. Khodadadi, C. Voigt, I. M. Mumtaz, Q. Cheng et al., Long-lived plasma cells are early and constantly generated in New Zealand Black/New Zealand White F1 mice and their therapeutic depletion requires a combined targeting of autoreactive plasma cells and their precursors, Arthritis ResTher, vol.17, p.39, 2015.

A. Tafuri, A. Shahinian, F. Bladt, S. K. Yoshinaga, J. M. Wakeham et al., ICOS is essential for effective T-helper-cell responses, Nature, vol.409, issue.6816, pp.105-114, 2001.

M. Taillardet, G. Haffar, P. Mondière, M. J. Asensio, H. Gheit et al., The thymus-independent immunity conferred by a pneumococcal polysaccharide is mediated by long-lived plasma cells, Blood, vol.114, issue.20, pp.4432-4472, 2009.

P. P. Tak, P. J. Mease, M. C. Genovese, J. Kremer, B. Haraoui et al., Safety and efficacy of ocrelizumab in patients with rheumatoid arthritis and an inadequate response to at least one tumor necrosis factor inhibitor: results of a forty-eight-week randomized, double-blind, placebo-controlled, parallel-group phase III trial, Arthritis Rheum, vol.64, issue.2, pp.360-70, 2012.

Y. Takahashi, P. R. Dutta, D. M. Cerasoli, and G. Kelsoe, In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. V. Affinity maturation develops in two stages of clonal selection, J Exp Med, vol.187, issue.6, pp.885-95, 1998.

S. M. Tan, D. Xu, V. Roschke, J. W. Perry, D. G. Arkfeld et al., Local production of B lymphocyte stimulator protein and APRIL in arthritic joints of patients with inflammatory arthritis, Arthritis Rheum, vol.48, issue.4, pp.982-92, 2003.

S. G. Tangye, C. S. Ma, R. Brink, and E. K. Deenick, The good, the bad and the ugly -TFH cells in human health and disease, Nat Rev Immunol, vol.13, issue.6, pp.412-438, 2013.

S. G. Tangye, Staying alive: regulation of plasma cell survival, TrendsImmunol, vol.32, issue.12, pp.595-602, 2011.

D. Tarlinton, B-cell memory: are subsets necessary?, Nat Rev Immunol, vol.6, issue.10, pp.785-90, 2006.

B. Terrier, Z. Amoura, P. Ravaud, E. Hachulla, R. Jouenne et al., Club Rhumatismes etInflammation. Safety and efficacy of rituximab in systemic lupus erythematosus:results from 136 patients from the French AutoImmunity and Rituximab registry, Arthritis Rheum, vol.62, issue.8, pp.2458-66, 2010.

L. W. Terstappen, S. Johnsen, I. M. Segers-nolten, and M. R. Loken, Identification and characterization of plasma cells in normal human bone marrow by high-resolution flow cytometry, Blood, vol.76, issue.9, pp.1739-1786, 1990.

M. Thien, T. G. Phan, S. Gardam, M. Amesbury, A. Basten et al., Excess BAFF rescues selfreactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches, Immunity, vol.20, issue.6, pp.785-98, 2004.

R. M. Thurlings, K. Vos, C. A. Wijbrandts, A. H. Zwinderman, D. M. Gerlag et al., Synovial tissue response to rituximab: mechanism of action and identification of biomarkers of response, Ann Rheum Dis, vol.67, issue.7, pp.917-942, 2008.

S. L. Tiegs, D. M. Russell, and D. Nemazee, Receptor editing in self-reactive bone marrow B cells, J Exp Med, vol.177, issue.4, pp.1009-1029, 1993.

S. K. Todd, R. J. Pepper, J. Draibe, A. Tanna, C. D. Pusey et al., Regulatory B cells are numerically but not functionally deficient in anti-neutrophil cytoplasm antibody-associated vasculitis, Rheumatology (Oxford), vol.53, issue.9, pp.1693-703, 2014.

K. Tokoyoda, T. Egawa, T. Sugiyama, B. I. Choi, and T. Nagasawa, Cellular niches controlling B lymphocyte behavior within bone marrow during development, Immunity, vol.20, issue.6, pp.707-725, 2004.

H. Toyama, S. Okada, M. Hatano, Y. Takahashi, N. Takeda et al., Memory B cells without somatic hypermutation are generated from Bcl6-deficient B cells, Immunity, vol.17, issue.3, pp.329-368, 2002.

C. A. Turner, D. H. Mack, and M. M. Davis, Blimp-1, a novel zinc finger-containing protein that can drive the maturation of B lymphocytes into immunoglobulin-secreting cells, Cell, vol.77, issue.2, pp.297-306, 1994.

Y. Ueda, K. Yang, S. J. Foster, M. Kondo, and G. Kelsoe, Inflammation controls B lymphopoiesis by regulating chemokine CXCL12 expression, J Exp Med, vol.199, issue.1, pp.47-58, 2004.

S. Unizony, N. Lim, D. J. Phippard, V. J. Carey, E. M. Miloslavsky et al., Peripheral CD5+ B cells in antineutrophil cytoplasmic antibody-associated vasculitis, Arthritis Rheumatol, vol.67, issue.2, pp.535-579, 2015.

R. F. Van-vollenhoven, S. Wax, Y. Li, and P. P. Tak, Safety and efficacy of atacicept in combination with rituximab for reducing the signs and symptoms of rheumatoid arthritis: a phase II, randomized, double-blind, placebo-controlled pilot trial, Arthritis Rheumatol, vol.67, issue.11, pp.2828-2864, 2015.

R. F. Van-vollenhoven, N. Kinnman, E. Vincent, S. Wax, and J. Bathon, Atacicept in patients with rheumatoid arthritis and an inadequate response to methotrexate:results of a phase II, randomized, placebocontrolled trial, Arthritis Rheum, vol.63, issue.7, pp.1782-92, 2011.

R. F. Van-vollenhoven, P. Emery, . Bingham-co-3rd, E. C. Keystone, R. Fleischmann et al., Longterm safety of patients receiving rituximab in rheumatoid arthritis clinical trials, J Rheumatol, vol.37, issue.3, pp.558-67, 2010.

E. Varfolomeev, F. Kischkel, F. Martin, D. Seshasayee, H. Wang et al., APRIL-deficient mice have normal immune system development, Mol Cell Biol, vol.24, issue.3, pp.997-1006, 2004.

N. Venhoff, L. Niessen, M. Kreuzaler, A. G. Rolink, F. Hässler et al., Reconstitution of the peripheral B lymphocyte compartment in patients with ANCA-associated vasculitides treated with rituximab for relapsing or refractory disease, Autoimmunity, vol.47, issue.6, pp.401-409, 2014.

G. D. Victora and M. C. Nussenzweig, Germinal centers, Annu Rev Immunol, vol.30, pp.429-57, 2012.

G. A. Viglianti, C. M. Lau, T. M. Hanley, B. A. Miko, and M. J. Shlomchik, Marshak-Rothstein A.Activation of autoreactive B cells by CpG dsDNA, Immunity, vol.19, issue.6, pp.837-884, 2003.

A. Vincent, Unravelling the pathogenesis of myasthenia gravis, Nat Rev Immunol, vol.2, issue.10, pp.797-804, 2002.

F. B. Vincent, D. Saulep-easton, W. A. Figgett, K. A. Fairfax, and F. Mackay, The BAFF/APRIL system: emerging functions beyond B cell biology and autoimmunity, Cytokine Growth Factor Rev, vol.24, issue.3, pp.203-218, 2013.

T. Vincent and N. Mechti, IL-6 regulates CD44 cell surface expression on human myeloma cells, Leukemia, vol.18, issue.5, pp.967-75, 2004.

C. G. Vinuesa, M. C. Cook, C. Angelucci, V. Athanasopoulos, L. Rui et al., A RING-type ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity, Nature, vol.435, issue.7041, pp.452-460, 2005.

C. G. Vinuesa, D. M. Sze, M. C. Cook, K. M. Toellner, G. G. Klaus et al., Recirculating and germinal center B cells differentiate into cells responsive to polysaccharide antigens, Eur J Immunol, vol.33, issue.2, pp.297-305, 2003.

E. M. Vital, S. Dass, M. H. Buch, K. Henshaw, C. T. Pease et al., B cell biomarkers of rituximab responses in systemic lupus erythematosus, Arthritis Rheum, vol.63, issue.10, pp.3038-3085, 2011.

E. M. Vital, S. Dass, A. C. Rawstron, M. H. Buch, V. Goëb et al., Management of nonresponse to rituximab in rheumatoid arthritis: predictors and outcome of re-treatment, Arthritis Rheum, vol.62, issue.5, pp.1273-1282, 2010.

D. Vlahakos, M. H. Foster, A. A. Ucci, K. J. Barrett, S. K. Datta et al., Murine monoclonal anti-DNA antibodies penetrate cells, bind to nuclei, and induce glomerular proliferation and proteinuria in vivo, J Am Soc Nephrol, vol.2, issue.8, pp.1345-54, 1992.

D. V. Vlahakos, M. H. Foster, S. Adams, M. Katz, A. A. Ucci et al., Anti-DNA antibodies form immune deposits at distinct glomerular and vascular sites, Kidney Int, vol.41, issue.6, pp.1690-700, 1992.

G. U. Von-bülow, J. M. Van-deursen, and R. J. Bram, Regulation of the T-independent humoral response by TACI, Immunity, vol.14, issue.5, pp.573-82, 2001.

K. A. Vora, L. C. Wang, S. P. Rao, Z. Y. Liu, G. R. Majeau et al., Cutting edge: germinal centers formed in the absence of B cell-activating factor belonging to the TNF family exhibit impaired maturation and function, J Immunol, vol.171, issue.2, pp.547-51, 2003.

D. J. Wallace, K. Hobbs, M. E. Clowse, M. Petri, V. Strand et al., Long-Term Safety and Efficacy of Epratuzumab in the Treatment of Moderate-toSevere Systemic Lupus Erythematosus: Results From an Open-Label Extension Study, Arthritis Care Res(Hoboken), vol.68, issue.4, pp.534-577, 2016.

D. J. Wallace, K. Kalunian, M. A. Petri, V. Strand, F. A. Houssiau et al., Efficacy and safety of epratuzumab in patients with moderate/severe active systemic lupus erythematosus: results from EMBLEM, a phase IIb, randomised, double-blind, placebo-controlled, multicentre study, Ann Rheum Dis, vol.73, issue.1, pp.183-90, 2014.

E. F. Wallin, E. C. Jolly, O. Suchánek, J. A. Bradley, M. Espéli et al., Human Tfollicular helper and T-follicular regulatory cell maintenance is independent of germinal centers, Blood, vol.124, issue.17, pp.2666-74, 2014.

W. Wang, J. Rangel-moreno, T. Owen, J. Barnard, S. Nevarez et al., Long-term B cell depletion in murine lupus eliminates autoantibody-secreting cells and is associated with alterations in the kidney plasma cell niche, J Immunol, vol.192, issue.7, pp.3011-3031, 2014.

Y. Wang and D. Bhattacharya, Adjuvant-specific regulation of long-term antibodyresponses by ZBTB20, J Exp Med, vol.211, issue.5, pp.841-56, 2014.

H. Wardemann, S. Yurasov, A. Schaefer, J. W. Young, E. Meffre et al., Predominant autoantibody production by early human B cell precursors, Science, vol.301, issue.5638, pp.1374-1381, 2003.

N. Wehrli, D. F. Legler, D. Finke, K. M. Toellner, P. Loetscher et al., Changing responsiveness to chemokines allow medullary plasmablasts to leave lymph nodes, Eur J Immunol, vol.31, issue.2, pp.609-625, 2001.

F. J. Weisel, G. V. Zuccarino-catania, M. Chikina, and M. J. Shlomchik, A Temporal Switch in the Germinal Center Determines Differential Output of Memory B and Plasma Cells, Immunity, vol.44, issue.1, pp.116-146, 2016.

O. Winter, K. Moser, E. Mohr, D. Zotos, H. Kaminski et al., Megakaryocytes constitute a functional component of a plasma cell niche in the bone marrow, Blood, vol.116, issue.11, pp.1867-75, 2010.

D. R. Withers, C. Fiorini, R. T. Fischer, R. Ettinger, P. E. Lipsky et al., T cell-dependent survival of CD20+ and CD20-plasma cells in human secondary lymphoid tissue, Blood, vol.109, issue.11, pp.4856-64, 2007.

H. Xiao, P. Heeringa, P. Hu, Z. Liu, M. Zhao et al., Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice, J Clin Invest, vol.110, issue.7, pp.955-63, 2002.

M. Yan, H. Wang, B. Chan, M. Roose-girma, S. Erickson et al., Activation and accumulation of B cells in TACI-deficient mice, Nat Immunol, vol.2, issue.7, pp.638-681, 2001.

K. Yanaba, J. D. Bouaziz, K. M. Haas, J. C. Poe, M. Fujimoto et al., A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses, Immunity, vol.28, issue.5, pp.639-50, 2008.

T. Yasuda, K. Kometani, N. Takahashi, Y. Imai, Y. Aiba et al., ERKs induce expression of the transcriptional repressor Blimp-1 and subsequent plasma cell differentiation, Sci Signal, vol.4, issue.169, p.25, 2011.

B. H. Ye, G. Cattoretti, Q. Shen, J. Zhang, N. Hawe et al., Dalla-Favera R. The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation, Nat Genet, vol.16, issue.2, pp.161-70, 1997.

S. Zehentmeier, K. Roth, Z. Cseresnyes, Ö. Sercan, K. Horn et al., Static and dynamic components synergize to form a stable survival niche for bone marrow plasma cells, Eur J Immunol, vol.44, issue.8, pp.2306-2323, 2014.

D. Zotos, J. M. Coquet, Y. Zhang, A. Light, D. Costa et al., IL-21 regulates germinal center B cell differentiation and proliferation through a B cell-intrinsic mechanism, J Exp Med, vol.207, issue.2, pp.365-78, 2010.